Clinical efficacy of botulinum toxin type A in the treatment of fasciitis pain .
Clinical efficacy of botulinum toxin type A in the treatment of fasciitis pain: A systematic review and meta-analysis.
Medicine (Baltimore). 2023 01-Jul;():. 10.1097/MD.0000000000034461Fourteen studies involving 537 patients with fasciitis were included in this systematic review and meta-analysis, comparing botulinum toxin type A (BoNT-A) injections to placebo or other control treatments. The primary outcome measured was the Visual Analog Scale (VAS) for pain reduction, with secondary measures including functional and disability scores. Pooled results demonstrated a significant reduction in VAS pain scores for BoNT-A compared to controls (P < .00001). Subgroup analyses showed the most substantial effects in plantar fasciitis, followed by lumbar back and neck/shoulder fasciitis. The findings suggest BoNT-A is a promising therapeutic option for fasciitis pain.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
